Dr. Gabriel Loor, associate professor in the Division of Cardiothoracic Transplantation and Circulatory Support at Baylor College of Medicine, has been awarded $75,000 by The JHL Foundation board of directors, for his EXPAND II research trial, where he is testing the outcomes of transplanted donor lungs that are transported, preserved, optimized and monitored on a portable organ care system device. The purposes of supporting Dr. Loor’s study of biomarker data to help determine whether an organ is safe for transplant and how the post-operative course might look after ex-vivo lung perfusion (EVLP). Dr. Loor received $325,000 in 2017 and then an additional $75,000 to continue to explore biomarkers.
Dr. Loor is credited with the first Donation after Cardiac Death (DCD) transplant in the United States using portable EVLP which keeps the lung viable and monitored throughout transportation. Dr. Loor also completed the first "breathing lung" transplant in Texas in 2017 and leads the development of the Baylor Lung Institute database for lung transplantation and tissue banking. He also works with translational science collaborations with the Texas Heart Institute Regenerative Medicine Department and participates in the interventional program for mitral valve and aortic valve disease here at Baylor College of Medicine.
Dr. Loor specializes in the clinical evaluation and surgical management of patients with advanced cardiothoracic disease including coronary artery, aortic and valvular heart disease. Dr. Loor has a special interest in advanced heart and lung failure and is the surgical director of the Baylor St. Luke's Medical Center Lung Transplantation Program.”